Publications

5808 Results

Southwest Oncology Group.

Authors
C Coltman, Jr
Journal / Conference
Cancer Suppl 65(supp 1):2385-2387
Year
1990

Age < 35 years is an adverse prognostic feature in premenopausal node-positive breast cancer patients (PTS) in Southwest Oncology Group studies.

Authors
K Albain;S Green;S Rivkin;K Osborne
Journal / Conference
ASCO 9:35(#132)
Year
1990
Research Committee(s)
Breast
Study Number(s)
SWOG-7436, SWOG-7827

Adjuvant combination chemotherapy (CMFV P) vs tamoxifen (TAM) vs CMFVP+TAM for postmenopausal women with ER+ operable breast cancer and positive axillary lymph nodes: An intergroup study.

Authors
S Rivkin;S Green;B Metch;A Cruz;R McDivitt;W Knight;J Glick;CK Osborne
Journal / Conference
ASCO 9:24(#87)
Year
1990
Research Committee(s)
Breast
Study Number(s)
SWOG-7827

Effect of colony-forming unit dose of connaught BCG on outcome to immunotherapy in superficial bladder cancer: A Southwest Oncology Group study.

Authors
B Blumenstein;D Lamm;MAS Jewett;G Humphries;L Boux;J Montie;P Scardino;H Grossman;D Crawford;JA Smith;T Stanisic
Journal / Conference
Journal of Urology 143(4):340A
Year
1990
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-8216/38

Correlation between progesterone receptor (PgR) and response to tamoxifen in patients (PTS) with estrogen receptor (ER) positive newly diagnosed metastatic breast cancer. A Southwest Oncology Group study.

Authors
T Melink;S Green;B Metch;W McGuire;C Fabian;R Pugh;B Tranum;J Hill;CK Osborne
Journal / Conference
ASCO 9:53(#202)
Year
1990
Research Committee(s)
Breast
Study Number(s)
SWOG-8228

Immaturity and dyspoiesis scoring: A system to discriminate benign vs. malignant plasmacytic proliferation.

Authors
SM Saeed;BKS Raman;R Pohlod
Journal / Conference
Modern Pathology 3:1(514)
Year
1990
Research Committee(s)
Myeloma
Study Number(s)
SWOG-8229/30

Pooled results from three randomized adjuvant studies of doxorubicin versus observation in soft tissue sarcoma: 10 year results.

Authors
K Antman;L Ryan;E Borden;W Wood;H Lerner;J Corson;R Carey;H Suit;S Balcerzak;M Sherman;L Baker
Journal / Conference
ASCO 9:311(#1204)
Year
1990
Research Committee(s)
Sarcoma
Study Number(s)
SWOG-8291, SWOG-8391

Cisplatin (CDDP) and mitotane in metastatic adrenal carcinoma: A Southwest Oncology Group study.

Authors
RM Bukowski;J Montie;D Crawford;M Wolf
Journal / Conference
ASCO 9:136(#527)
Year
1990
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-8325

Dose intensity is not associated with subsequent survival after adjustment for known prognostic factors in non-Hodgkin's lymphoma patients treated with m-BACOD, ProMace-CytaBOM, and MACOP-B on Southwest Oncology Group study.

Authors
S Dahlberg;TP Miller;B Dana;J Weick;RI Fisher
Journal / Conference
ASCO 9:225(#986)
Year
1990
Research Committee(s)
Lymphoma
Study Number(s)
SWOG-8410, SWOG-8503, SWOG-8508

Assessment of treatment costs for carboplatin and cisplatin.

Authors
E Hannigan;D Alberts;S Green;R O'Toole;N Mason-Liddil;E Surwit;D Stock-Novack;R Goldberg;V Malviya;W Nahhas;R Canetta;R Thomas
Journal / Conference
ASCO 9:337(#1305)
Year
1990
Research Committee(s)
Gynecologic
Study Number(s)
SWOG-8412